Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs >

DelMar Pharmaceuticals, Inc. (DMPI)

Add DMPI Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/20/2017 7:11:47 PM - Followers: 20 - Board type: Free - Posts Today: 24

Del Mar Pharmaceuticals

Del Mar Pharma is developing new drug candidates targeting orphan cancer indications representing market opportunities in the US$100s of millions in North America and potentially billions of dollars worldwide. We aim to develop products that will have a high impact in patient care and a high return for our investors.
In order to accelerate our development timelines and reduce technical risk, we leverage existing clinical and commercial data from a wide range of sources. This business model has been well validated and demonstrated to position for investor exit with significant upside, even prior to commercialization.

Key elements of our business strategy include:

  • Leveraging existing human clinical data to support new regulatory filings with the U.S. FDA, Health Canada and the European Medicines Agency (EMEA).
  • Advancing our products into orphan drug indications where patients are failing modern biologic or targeted therapy in order to obtain a guarantee of market exclusivity, attractive reimbursement, and high-likelihood of accelerated product approvals.
  • Establishing new intellectual property around our product candidates, including use, manufacturing, chemical composition and mechanism patent claims.
  • Obtaining commercial drug product from existing commercial manufacturers to accelerate entry into human clinical trials and reduce development costs.
  • Investigating the molecular mechanism of our drug candidates in order to establish additional patent claims and also to identify patients most likely to benefit from therapy (personalized medicine approach).
  • Commercializing our products through a combination of direct marketing and collaborative partnerships. For example, we target marketing our products to the small number of leading cancer centers in North America who specialize in the treatment of resistant orphan cancers and establishing sales and marketing partnerships for "large volume" tumor markets and in international markets including Europe & Asia.
  • Generating near-term revenue by leveraging opportunities in markets where our drug candidates are already approved or can be readily registered.
  • Operating on a "virtual" basis to minimize fixed-research costs while maintaining access to a highly-experienced and skilled workforce.

Product Development Programs: VAL-083

Del Mar Pharma's first product candidate, VAL-083, benefits from an historical investment of more than US$50 million by the National Cancer Institute (NCI) in the United States. The drug is well-characterized and has been studied in more than 40 Phase I & Phase II NCI-sponsored human clinical trials in the United States and in Europe. VAL-083 is approved as a cancer chemotherapeutic in China for the treatment of chronic myelogenous leukemia and solid tumors, including lung cancer.


Cannabis Stocks News
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
News News Alert: DelMar Pharmaceuticals Announces $10 Million Registered Direct Offering Priced At-The-Market 09/20/2017 03:31:00 PM
#221   Re: xyz1002 chrislal 09/20/17 07:11:47 PM
#220   Lol. Where was the last offering? What was Jumpinjackas 09/20/17 06:24:44 PM
#219   They sold 8M shares at $1.25. xyz1002 09/20/17 06:10:40 PM
#218   I bought 1k at $2. barbobbie 09/20/17 05:52:04 PM
#217   Ref; xyz1002 chrislal 09/20/17 05:41:38 PM
#216   * * $DMPI Video Chart Analysis 9/20/17 * * ClayTrader 09/20/17 05:18:16 PM
#215   Yes I hope it gets back up some Stoquer1 09/20/17 04:28:56 PM
#214   I don't think there was any dilution today. xyz1002 09/20/17 04:22:21 PM
#213   They sold $10M shares at $1.25. Once the xyz1002 09/20/17 04:12:52 PM
#212   I held from quite a bit higher got Stoquer1 09/20/17 04:05:51 PM
#211   They sold 8M shares at $1.25 Folks xyz1002 09/20/17 03:55:11 PM
#210   Dilution at 3:30 willlbone 09/20/17 03:51:40 PM
#209   I tried to short it, but couldn't from Jumpinjackas 09/20/17 03:37:06 PM
#208   made some easy money here Tdash 09/20/17 11:10:15 AM
#207   Thanks, man as I said before just keep Suarezzz1111 09/20/17 10:56:57 AM
#206   Sorry you missed just keep watch for next time Suarezzz1111 09/20/17 10:54:33 AM
#205   Same here..especially when you double up Suarezzz1111 09/20/17 10:50:50 AM
#204   I just sold at just over $2.23. That cjstocksup 09/20/17 10:46:41 AM
#203   I didn't get in... not that lucky twice! Jumpinjackas 09/20/17 10:05:05 AM
#202   And today we know why! cjstocksup 09/20/17 10:01:17 AM
#201   Yea this morning I took a nice chunk Suarezzz1111 09/20/17 09:53:17 AM
#200   Did you sell any? Jumpinjackas 09/20/17 09:47:37 AM
#199   Congratulations! It is looking good so far. Funny, Jumpinjackas 09/20/17 09:47:13 AM
#198   Please tell me you're watching the open DMPI Suarezzz1111 09/20/17 09:38:43 AM
#197   I truly don't know could be some selling Suarezzz1111 09/19/17 03:28:43 PM
#196   Did you see the news and pop other Jumpinjackas 09/19/17 03:08:13 PM
#195   Dude have watched DMPI today it is the Suarezzz1111 09/19/17 02:59:24 PM
#194   There is some truth to that but I'm Suarezzz1111 09/19/17 02:23:22 PM
#193   I agree, science looks solid.. But at this Jumpinjackas 09/19/17 12:31:13 PM
#192   They have dropped a bit but give it Suarezzz1111 09/19/17 10:14:40 AM
#191   VBLT seems like a better "bet" in the Jumpinjackas 09/14/17 03:33:15 PM
#190   The Renshaw presentation for DMPI was interesting. Listen jssdmm 09/13/17 02:02:24 PM
#189   Watching from the sidelines may be a wise jssdmm 09/06/17 02:03:25 PM
#188   Luckily sold at 1.31 last week. This does Jumpinjackas 09/06/17 12:17:09 PM
#187   I hope so. It does look like the Jumpinjackas 08/21/17 01:33:40 AM
#186   Nice timing! jssdmm 08/18/17 05:25:34 PM
#185   I ended up picking up some today. I Jumpinjackas 08/17/17 10:11:04 PM
#184   I think you're right about getting some under jssdmm 08/17/17 08:47:41 PM
#183   "17.8 million market cap is very enticing right? " Jumpinjackas 08/17/17 11:42:55 AM
#182   Interesting about Maxim. jssdmm 08/16/17 05:40:11 PM
#181   Maxim contradicts your statement. This make sense why Jumpinjackas 08/16/17 12:28:13 PM
#180   Agreed on many points. Jumpinjackas 08/15/17 11:43:13 PM
#179   Yup it appears it took a bit longer jssdmm 08/14/17 04:11:11 PM
#178   It took almost a year to kick off Jumpinjackas 08/10/17 11:16:18 AM
#176   12$ price target,bought 2.10 $ DMPI NateMoneyMill 07/23/17 03:49:49 PM
#175   PM news Awl416 06/22/17 11:00:17 AM
#174   Why the sudden surge? WOW nice Ivegotanace2 06/22/17 10:14:20 AM
#173   Looking tasty... Got me some 2,29 stop 2,03 europtiger 06/22/17 10:09:40 AM
#172   Share price is ridiculously cheap for a drug The Lawman 06/13/17 11:44:59 PM
#171   Time to accumulate. jcool888 06/13/17 09:18:55 AM